Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia: A Double-blind Randomized Controlled Trial

NCT07797673 is registered in ClinicalTrials.gov with Dr Cipto Mangunkusumo General Hospital as lead sponsor.

NCT NCT07797673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07797673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia: A Double-blind Randomized Controlled Trial
Lead sponsor
Dr Cipto Mangunkusumo General Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
September 1, 2026
Completion date
December 31, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary atresia, kasai operation, liver fibrosis, liver function failure, stem cell